ShangPharma Biologics Head Mitchell Reff On Biologics R&D In China: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
ShangPharma’s new Chief Biologic Officer Mitchell Reff discusses the company’s expansion into biologics and his views on biologics development in China.